" class="no-js "lang="en-US"> Mario Franco Ruiz, H&T Presspart, on Medical Device Innovation
Monday, June 05, 2023

Breaking News

Providence Therapeutics Announces Partnership with University Health Network (UHN) for mRNA Therapeutic Discovery and Development Affini-T Therapeutics Appoints Industry Veteran Thaminda Ramanayake, M.S., MBA, as Chief Business Officer Feinstein Institutes Bioelectronic Medicine Researchers Stimulate Vagus Nerve to Reduce Bleeding in Hemophilia Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in Lupus Nephritis Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for ARCT-810, mRNA Therapeutic Candidate for Ornithine Transcarbamylase Deficiency CANbridge Announces Marketing Approval of CAN108 in China for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome GC Biopharma Receives a Business License for the Construction of a Plasma Fractionation Plant and Technology Transfer in Indonesia Cytovation Raises $8 Million in Series A Extension Financing Round for Clinical Advancement of CyPep-1, a First-in-class Targeted Tumor Membrane Immunotherapy FUJIFILM Cellular Dynamics Introduces First-of-its-Kind Human iPSC-derived Blood-Brain Barrier Isogenic Kit Landmark Bio Partners With InnDura Therapeutics to Advance Immune Cell Therapy Research

March 7 2023

Mario Franco Ruiz, H&T Presspart, on Innovation for Medical Devices

In the video, Mario Franco Ruiz, Sales Manager at H&T Presspart, discusses the company’s latest offerings at the Pharmapack event. He explains that H&T Presspart is showcasing a range of innovative products, including new inhalers and dosing systems, which are designed to enhance the user experience and improve the accuracy and efficiency of drug delivery.

Mario also discusses the importance of not just attracting new customers, but to strengthen the relationship between H&T Presspart and its existing customers.

Overall, Mario emphasizes H&T Presspart’s commitment to innovation and customer satisfaction, and he encourages attendees at Pharmapack to visit the company’s booth to learn more about its latest products and services.

  1. Providence Therapeutics Announces Partnership with University Health Network (UHN) for mRNA Therapeutic Discovery and Development

    News

     Read more
  2. Affini-T Therapeutics Appoints Industry Veteran Thaminda Ramanayake, M.S., MBA, as Chief Business Officer

    Appointments

     Read more
  3. Feinstein Institutes Bioelectronic Medicine Researchers Stimulate Vagus Nerve to Reduce Bleeding in Hemophilia

    Diseases

     Read more
  4. Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in Lupus Nephritis

    Drug Development

     Read more
  5. Arcturus Therapeutics Receives U.S. FDA Fast Track Designation for ARCT-810, mRNA Therapeutic Candidate for Ornithine Transcarbamylase Deficiency

    Drug Development

     Read more
More On